CytoSorb registry for critically ill patients needing blood treatment
Part of Blood & lymphatic, Bones, joints & muscles, Digestive system, Heart & circulation, Infections, Injuries & trauma, Lungs & breathing, Mental health clinical trials.
This registry collects information about critically ill patients who receive the CytoSorb 300 mL blood treatment. It may help doctors better understand when the treatment works best and when it should not be used.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your care team plans to use (or already used) the CytoSorb 300 mL device
- You or your legal representative can give consent to join this registry
- The CytoSorb use is not only to remove blood thinners (anti-clotting medicines)
- It is not only for heart surgery use during cardiac surgery
- If a serious medical issue happens after consent that makes CytoSorb unsafe or inappropriate, you may not be able to continue
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device called CytoSorb that filters the blood to reduce inflammation in patients with sudden worsening of chronic liver disease. It may help support organ function and recovery.
This trial tests whether a blood filtering treatment called hemoadsorption can help protect blood vessels in people with septic shock. It may be an option for patients who are already on strong blood pressure medications and steroids.
This registry collects medical information from adults who have suspected or proven serious infection causing body organ problems. It helps researchers better understand what happens in severe sepsis and septic shock and may guide future care.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This trial is a registry that collects information about people with cardiogenic shock to better understand outcomes and improve management. It may help by contributing real-world data on what treatments and timing work best for different heart-related shock causes.
This registry collects information from patients admitted to the hospital with cardiogenic shock—a serious condition where the heart cannot pump enough blood to the body. Doctors will gather data to better understand what happens to these patients and how to improve their care.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.